Eton Pharmaceuticals, Inc. ETON Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Eton Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s debt-to-equity?
- Eton Pharmaceuticals, Inc. (ETON) reported debt-to-equity of 1× in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s debt-to-equity changed year-over-year?
- Eton Pharmaceuticals, Inc.'s debt-to-equity decreased by 17.2% year-over-year, from 1.2× to 1×.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s debt-to-equity?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s debt-to-equity has grown at a 22.6% compound annual growth rate (CAGR), from 0.4× to 1.2×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.